Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Coya Therapeutics, Inc. | Chief Medical Officer | Common Stock, par value $0.0001 per share | 2.71K | $20K | $7.37 | Nov 11, 2024 | Direct |
Coya Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 70.6K | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
COYA | Coya Therapeutics, Inc. | Nov 11, 2024 | 1 | $20K | 4 | Nov 12, 2024 | Chief Medical Officer |
COYA | Coya Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Chief Medical Officer |
COYA | Coya Therapeutics, Inc. | Jan 31, 2024 | 2 | $0 | 4 | Feb 2, 2024 | Chief Medical Officer |
COYA | Coya Therapeutics, Inc. | Jul 17, 2023 | 1 | $0 | 4 | Jul 19, 2023 | Chief Medical Officer |
COYA | Coya Therapeutics, Inc. | Jul 17, 2023 | 0 | $0 | 3 | Jul 19, 2023 | Chief Medical Officer |